125 results on '"Sanjiv S. Gambhir"'
Search Results
2. ICOS immunoPET enables visualization of activated T cells and early diagnosis of murine acute gastrointestinal GvHD
3. Data from Assessment of Tumor Redox Status through (S)-4-(3-[18F]fluoropropyl)-L-Glutamic Acid PET Imaging of System xc− Activity
4. Supplementary Data from Assessment of Tumor Redox Status through (S)-4-(3-[18F]fluoropropyl)-L-Glutamic Acid PET Imaging of System xc− Activity
5. Supplementary Figure 4 from Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening
6. Supplementary Figures 1-13 from A c-Myc Activation Sensor-Based High-Throughput Drug Screening Identifies an Antineoplastic Effect of Nitazoxanide
7. Supplementary Table 5 from Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening
8. Supplementary Figure 3 from Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening
9. Supplementary Table 2 from Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening
10. Data from Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening
11. Supplementary Table 3 from Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening
12. Data from A c-Myc Activation Sensor-Based High-Throughput Drug Screening Identifies an Antineoplastic Effect of Nitazoxanide
13. Supplementary Table 4 from Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening
14. Supplementary Methods from Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening
15. Supplementary Figure 1 from Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening
16. Supplementary Table 1 from Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening
17. Supplementary Figure 2 from Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening
18. Supplementary Data from Microvesicle-Mediated Delivery of Minicircle DNA Results in Effective Gene-Directed Enzyme Prodrug Cancer Therapy
19. Supplemental Figure S5 from 18F-FAZA PET Imaging Response Tracks the Reoxygenation of Tumors in Mice upon Treatment with the Mitochondrial Complex I Inhibitor BAY 87-2243
20. Supplementary Figures 1 - 4 from A High-Affinity, High-Stability Photoacoustic Agent for Imaging Gastrin-Releasing Peptide Receptor in Prostate Cancer
21. Supplementary Data from A Novel Engineered Small Protein for Positron Emission Tomography Imaging of Human Programmed Death Ligand-1: Validation in Mouse Models and Human Cancer Tissues
22. Supplemental Figure 1 from Whole-body PET Imaging of T-cell Response to Glioblastoma
23. Data from ICOS Is an Indicator of T-cell–Mediated Response to Cancer Immunotherapy
24. Data from Pharmacokinetically Stabilized Cystine Knot Peptides That Bind Alpha-v-Beta-6 Integrin with Single-Digit Nanomolar Affinities for Detection of Pancreatic Cancer
25. Figure S2 from PET Reporter Gene Imaging and Ganciclovir-Mediated Ablation of Chimeric Antigen Receptor T Cells in Solid Tumors
26. Supplementary Video2 from Whole-body PET Imaging of T-cell Response to Glioblastoma
27. Supplemental Video 3 from Visualization of Activated T Cells by OX40-ImmunoPET as a Strategy for Diagnosis of Acute Graft-versus-Host Disease
28. Video S1 from ICOS Is an Indicator of T-cell–Mediated Response to Cancer Immunotherapy
29. Supplementary Figure 2 from ICOS Is an Indicator of T-cell–Mediated Response to Cancer Immunotherapy
30. Video S5 from ICOS Is an Indicator of T-cell–Mediated Response to Cancer Immunotherapy
31. Supplemental Video 4 from Visualization of Activated T Cells by OX40-ImmunoPET as a Strategy for Diagnosis of Acute Graft-versus-Host Disease
32. Video S4 from ICOS Is an Indicator of T-cell–Mediated Response to Cancer Immunotherapy
33. Data from PET Reporter Gene Imaging and Ganciclovir-Mediated Ablation of Chimeric Antigen Receptor T Cells in Solid Tumors
34. Video from A Novel Engineered Small Protein for Positron Emission Tomography Imaging of Human Programmed Death Ligand-1: Validation in Mouse Models and Human Cancer Tissues
35. Supplementary Tables from Preclinical Efficacy of the Anti-Hepatocyte Growth Factor Antibody Ficlatuzumab in a Mouse Brain Orthotopic Glioma Model Evaluated by Bioluminescence, PET, and MRI
36. Video S2 from ICOS Is an Indicator of T-cell–Mediated Response to Cancer Immunotherapy
37. Supplementary Figure 3 from ICOS Is an Indicator of T-cell–Mediated Response to Cancer Immunotherapy
38. Supplementary Data from Multiparametric Photoacoustic Analysis of Human Thyroid Cancers In Vivo
39. Video S6 from ICOS Is an Indicator of T-cell–Mediated Response to Cancer Immunotherapy
40. Supplementary Figures from Preclinical Efficacy of the Anti-Hepatocyte Growth Factor Antibody Ficlatuzumab in a Mouse Brain Orthotopic Glioma Model Evaluated by Bioluminescence, PET, and MRI
41. Supplemental Materials and Methods from A Systematic Comparison of 18F-C-SNAT to Established Radiotracer Imaging Agents for the Detection of Tumor Response to Treatment
42. Detailed overview 510(k) cleared imaging devices from Regulatory Aspects of Optical Methods and Exogenous Targets for Cancer Detection
43. Supplemental Figure 2 from Whole-body PET Imaging of T-cell Response to Glioblastoma
44. Movie S1 from Assessment of Tumor Redox Status through (S)-4-(3-[18F]fluoropropyl)-L-Glutamic Acid PET Imaging of System xc− Activity
45. Figure S3 from PET Reporter Gene Imaging and Ganciclovir-Mediated Ablation of Chimeric Antigen Receptor T Cells in Solid Tumors
46. Data from A Systematic Comparison of 18F-C-SNAT to Established Radiotracer Imaging Agents for the Detection of Tumor Response to Treatment
47. Supplementary data from Development and Preclinical Validation of a Cysteine Knottin Peptide Targeting Integrin αvβ6 for Near-infrared Fluorescent-guided Surgery in Pancreatic Cancer
48. Supplemental Video M3 from A Systematic Comparison of 18F-C-SNAT to Established Radiotracer Imaging Agents for the Detection of Tumor Response to Treatment
49. Supplementary Methods, Figures 1-5, Tables 1-2 from Pharmacokinetically Stabilized Cystine Knot Peptides That Bind Alpha-v-Beta-6 Integrin with Single-Digit Nanomolar Affinities for Detection of Pancreatic Cancer
50. Figure S3 from PET Imaging of TIGIT Expression on Tumor-Infiltrating Lymphocytes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.